Mandate

Vinge advises Lantmännen in connection with the divestment of Swecon to Volvo Construction Equipment

Lantmännen Ek för has signed an agreement to divest Swecon to Volvo Construction Equipment (Volvo CE). Volvo CE will pay SEK 7 billion for the acquisition. The transaction is subject to regulatory approvals and is expected to be completed during the second half of 2025.

The transaction includes Swecon’s entire business scope, i.e. sales of products and services, rental operations, aftermarket services and customer support as well as offices, workshop facilities and 1,400 employees. The deal also includes Entrack. Swecon has been part of Lantmännen since its inception 25 years ago, and Swecon’s net sales in 2024 amounted to 10 billion SEK. Volvo CE sees this as a strategic move to further invest in retail operations in key markets; Germany, which is Europe’s largest construction equipment market, Sweden, Volvo CE´s home market as well as Estonia, Latvia and Lithuania. In addition to the currently owned retail operations footprint, this acquisition will mean Volvo CE will own and manage the majority of the company´s business in Europe, making retail core for Volvo CE in Europe. 

Vinges team mainly consisted of Christina Kokko, Gustav Wahlberg, Alex Forsberg and Josef Groow (M&A), Eva Fredriksson and Elis Allmark (IT/TSA), Marcus Glader and Hampus Peterson (EU, Competition and Regulatory) Christoffer Nordin (Commercial agreements) and Johanna Engström and Emy Rydén (Transaction Support Coordinators). 

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge advises KEYTO Group in connection with the acquisition of Smartify

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Smartify Sverige AB joins KEYTO Group.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026